ObjectiveTo identify lipid markers of blastocyst implantation and ongoing pregnancy by
day three culture medium mass spectrometry (MS) fingerprinting.MethodsFor this study, 33 culture media samples were harvested on day three, from 22
patients undergoing day five embryo transfers. All embryos achieved the
blastocyst stage and were split into groups based on their implantation
(Negative Implantation, n= 14 and Positive Implantation, n= 19). The
positive implantation cycles resulted in successful ongoing pregnancies. The
lipid extraction was performed by the Bligh-Dyer protocol and mass spectra
were obtained with a direct infusion into a Q-Tof mass spectrometer. The
data obtained was analyzed by Principal Component Analysis (PCA) and Partial
Least Square Discrimination Analysis (PLS-DA). The statistical analysis was
performed using the Metabo-Analyst 2.0.ResultsThe variable importance in the projection (VIP) plot of the PLS-DA provided a
list of four ions, in the positive mode, with an area under the curve (AUC)
of 73.5%; and eight ions, in the negative mode, with and AUC of 72.0%. For
both positive and negative modes, possible biomarkers for the negative
implantation were identified by the lipidmaps: phosphoethanolamine,
dicarboxylic acids, glycerophosphoglycerol, glycerophosphocholine,
glicerophosphoinositol, phosphoethanolamine and unsaturated fat acids. The
other ions were not identified. These lipids are involved in the GPI anchor
biosynthesis and synthesis of lycerophospholipids and phosphate
inositol.ConclusionMS fingerprinting is useful to identify blastocysts that fail to implant, and
therefore this technique could be incorporated into the laboratory routine,
adjunct to morphology evaluation to identify embryos that should not be
transferred.